Clincosm LogoSign in Get a demo

Mantle Cell Lymphoma

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mantle Cell Lymphoma Trial in Worldwide (Bendamustine, Rituximab, Ibrutinib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +201 more
Jan 27, 2023

CD20 Positive, Mantle Cell Lymphoma Trial in United States (procedure, other, biological)

Recruiting
  • CD20 Positive
  • Mantle Cell Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Birmingham, Alabama
  • +318 more
Jan 3, 2023

Mantle Cell Lymphoma Trial in United States (Venetoclax, Bendamustine, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Urbana, Illinois
  • +9 more
Nov 10, 2022

A Disease Registry of Patients With Mantle Cell Lymphoma

Active, not recruiting
  • Mantle Cell Lymphoma
    • Montgomery, Alabama
    • +33 more
    Oct 28, 2022

    Mantle Cell Lymphoma Trial in Duarte, Ann Arbor, Columbus (Venetoclax, Lenalidomide, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Duarte, California
    • +2 more
    Oct 18, 2022

    DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

    Terminated
    • Diffuse Large B-Cell Lymphoma
    • +4 more
    • Ublituximab
    • +2 more
    • Birmingham, Alabama
    • +167 more
    Jul 20, 2022

    Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)

    Recruiting
    • Diffuse Large B-cell Lymphoma
    • +7 more
    • GEN3009
    • Epcoritamab
    • Tucson, Arizona
    • +31 more
    Jul 1, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia
    • +6 more
    • Duarte, California
    • +165 more
    Mar 24, 2022

    Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

    Recruiting
    • Malignancy
    • +14 more
    • Scottsdale, Arizona
    • +17 more
    Mar 7, 2022

    Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,

    Recruiting
    • Hematologic Diseases
    • +11 more
    • Ann Arbor, Michigan
      University of Michigan Health System
    Dec 2, 2021

    Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow

    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    Nov 2, 2021

    Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

    Terminated
    • Lymphoma, T-Cell, Cutaneous
    • +6 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jan 20, 2021

    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Entospletinib MM
    • Entospletinib SDD
    • Birmingham, Alabama
    • +47 more
    Nov 2, 2020

    Mantle Cell Lymphoma Trial in Ann Arbor (Bortezomib, Ibrutinib)

    Withdrawn
    • Mantle Cell Lymphoma
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jun 18, 2020

    Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

    Completed
    • Mantle Cell Lymphoma
    • La Jolla, California
    • +56 more
    May 27, 2016